By Karen J. Leesburg The American Cancer Society has a new way to help people combat their addiction to nicotine: The nicotine salt.
In a report on Monday, the ACS said the drug, which combines nicotine salts with a vitamin to promote brain health, has the potential to be a revolutionary way to combat nicotine addiction.
For more than two decades, scientists have studied the effects of nicotine and related compounds on the brain, and the results have been clear.
Smoking causes a massive amount of damage to the brain that can lead to memory loss, memory impairment and even Alzheimer’s disease.
Nicotine is a powerful neurotoxin that causes brain cells to die and to become inactive, which leads to memory problems and problems with learning.
But the FDA has banned smoking in the U.S. since 1996, and researchers are not sure why that hasn’t been the case with nicotine.
Researchers are currently working to develop an alternative way to treat nicotine addiction, and that could be the solution.
Dr. Michael D. Lippman, director of the National Institute on Drug Abuse, is leading the effort to develop nicotine-based therapies.
The FDA has been slow to approve new nicotine therapies, because of concerns about side effects and possible addiction.
In a new study published in the journal Annals of Internal Medicine, Lippmann and his team took a different approach.
They studied how a combination of nicotine salts and vitamins could prevent memory loss in mice.
They found that, in mice, the nicotine-derived vitamins helped the brain to rewire itself, even after they stopped smoking.
In fact, the researchers said they could see some improvement in mice with memory loss after just six weeks of treatment.
This research is important because it could pave the way for more effective treatments for nicotine addiction and memory loss.
It could also open the door to a whole new class of treatments, including the drugs nicotine antagonists, which are being developed by Lippmans team, and nicotine patch, which he is developing for people with nicotine addiction or dementia.
But while nicotine may be the key to treating nicotine addiction in humans, it is not the only way to fight nicotine addiction that is working.
There are a variety of other ways to fight addiction and nicotine dependence, but nicotine salt is one of the most promising.
Nicotine salts are available in the form of tablets, powders, nasal sprays, patches and gum.
The combination of vitamins and nicotine is the most powerful nicotine blocker that is available.
The most popular type of nicotine salt, called NRT, is made from nicotine, propylene glycol, propyl paraben and other ingredients.
The FDA has approved NRT for use in nasal spray products, but it is only available as an aerosol and has not yet been approved for use on the body.
But if nicotine salts can be used safely and effectively in the body, then they can be a great alternative to smoking, said Dr. Lizzie W. Risley, president and CEO of the American Association for the Advancement of Science.
She is hopeful that the combination of the vitamin-nicotine salt and the vitamins will help people quit smoking, but she is not optimistic that nicotine salts will be approved for the body as a medicine.
“We need to see the results,” she said.
“We need more clinical trials.”
Dr. Ristley said the FDA is reviewing NRT.
“They want to see if NRT is safe and effective,” she added.
“If they do not see that, then we’re going to be concerned about this.”
A lot of people who have nicotine addiction have been taking NRT as a preventative measure for years.
However, the FDA’s current policy has left some people unable to use NRT because it is too expensive.
In the report, the American Cancer Association said NRT has already been shown to be effective in preventing and treating nicotine-related brain diseases and other diseases, and is being tested in other research projects.
But Risleys research team hopes to find a way to test nicotine salts for its own potential benefits.
“I am optimistic that the FDA will approve NRT and nicotine salts,” she told ABC News.
“It’s the first FDA-approved drug for this type of use.”